Platform

A Platform Approach to Medical Technology

Medfiniti integrates intellectual property, treatment delivery, and platform infrastructure into a unified model designed to support scalable clinical deployment and long-term value creation.

Platform Advantage

Built as a system, not a single product

Integrated Technology Layer

The platform is built on a non-thermal energy system that supports precise treatment while enabling expansion across multiple clinical applications.

Aligned Operating Model

The structure aligns physician utilization, platform infrastructure, and intellectual property into a single economic system rather than isolated product revenue streams.

Data-Enabled Foundation

The platform is designed to support compliant data capture and future clinical intelligence capabilities as part of its core architecture.

Architecture

How the platform is organized

Medfiniti is structured as a platform company, separating IP, management, and operations to enable scalable growth and capital efficiency.

Medfiniti, Inc. is a medical technology platform holding company that develops and scales specialty healthcare technologies through dedicated subsidiaries for intellectual property, platform management, and commercial operations. HemWell MD International, Inc., a wholly owned Medfiniti subsidiary, manages the HemWell platform and owns HemWell MD, LLC, the U.S. commercial operating entity.

Medfiniti, Inc.
Parent Holding Company

Responsible for capital allocation, strategic direction, and overall platform oversight across all operating entities.

Medfiniti IP, LLC
Intellectual Property Entity

Owns core technology, patents, trademarks, and related platform assets. Licenses IP to operating entities in exchange for royalty economics.

Platform Verticals (Tier 3)
HemWell MD International, Inc.
Global Management

Responsible for licensing, operating standards, commercialization support, and the infrastructure that underpins platform expansion globally.

Future MedTech 2
Under Evaluation

Potential future clinical vertical. Platform infrastructure designed to support disciplined expansion into adjacent specialties.

Future MedTech 3
Under Evaluation

Potential future clinical vertical. No new platform infrastructure required to support additional operating entities.

Operating Subsidiaries
HemWell MD, LLC
North America
Operations
HemWell MD GOV, LLC
Government & Military
Operations
HemWell MD B.V.
E.U. / U.K.
Operations
HemWell MD GCC
Middle East
Operations
Economic Model

How value flows through the platform

01
Physician Utilization
Physicians use the platform in clinical practice to deliver treatments.
02
Procedure Revenue
Per-procedure fees and consumables generate recurring revenue.
03
Platform Management Fees
Infrastructure, commercialization, and support layers capture value.
04
IP Royalty Economics
IP entity receives royalties from platform activity.
05
Capital Allocation
Parent company directs capital and expansion strategy.

Why this structure matters

Protects intellectual property in a dedicated entity

Separates platform assets from operating risk

Supports scalable multi-specialty expansion

Enables recurring revenue and royalty streams

Designed for institutional investment and growth